SRI 31215 TFA

SKU: orb1301758

Description

SRI 31215 TFA is a small molecule triplex inhibitor that potently targets matriptase, hepsin, and HGFA, mimicking the function of endogenous HAI-1/2 proteins. It is a valuable research tool for studying HGF/c-Met signaling pathways in cancer metastasis and tissue repair, with applications in both in vitro enzymatic assays and cell-based studies.

Research Area

Immunology & Inflammation, Signal Transduction

Key Properties

• CAS Number: 1832686-44-8
• MW: 533.6
• Purity: 98.25% (May vary between batches)
• Formula: C₂₇H₃₄F₃N₅O₃
• SMILES: OC(=O)C(F)(F)F.CC1CN(CC2CCN(Cc3ccccc3)CC2)C(=O)N(C1)c1cccc(c1)C(N)=N
• Target: c-Met/HGFR
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.75 mM);DMSO:25 mg/mL (46.85 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

SRI31215, SRI-31215, SRI 31215 TFA, HGFR, HGFA, hepsin, matriptase, c-Met/HGFR, cMet/HGFR, c-Met, cMet

Quick Database Links

Gene Symbol

c-Met/HGFR